drugset / Trial / NCT01153620

The Antiseptic Efficacy and Tolerability of Lavasept® 0.04% on Acute Traumatic Wounds

NCT01153620

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The primary objective of the study is to assess the antiseptic efficacy of Lavasept 0.04% when used as an antiseptic agent and to compare these with Ringers' solution in patients with acute traumatic wounds.

Timeline

Start
2010-08
Primary completion
2011-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Polihexanide Other / unclassified 0.04 % Topical
Comparator Polihexanide Other / unclassified 50 ml Topical

Indications

No indication recorded.